Frank Stowasser

USPTO Granted Patents = 13 (Patent Applications = 11)

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 29(Granted Patents)

Location History:

Murg, DE (2011 - 2019)
Mürg, DE (2019)
Basel, CH (2016 - 2022)

Company Filing History:

Hoffmann-la Roche Inc.

where one patent can have more than one assignee

Years Active: 2011-2022

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11230559 - Solid forms of [(1 S)-1 -[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-D]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-Yl]proptl] acetate (2022-01-25),

2. 10786571 - Hydrophilic gel for topical delivery of 5-aminolevulinic acid (2020-09-29),

3. 10314784 - Compositions of glycopyrronium salt for inhalation (2019-06-11),

4. 10188696 - Pharmaceutical compositions (2019-01-29),

5. 9949979 - Use of inhibitors of the activity or function of PI3K (2018-04-24),

6. 9499536 - Tetrahydro-pyrido-pyrimidine derivatives (2016-11-22),

7. 9006270 - Polymorphs of (S)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide (2015-04-14),

8. 8653092 - Tetrahydro-pyrido-pyrimidine derivatives (2014-02-18),

9. 8563556 - Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one lactic acid salts (2013-10-22),

10. 8436177 - Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile (2013-05-07),

11. 8178566 - Crystal form of epothilone B and use in pharmaceutical compositions (2012-05-15),

12. 8119841 - Crystalline forms of aliskiren hemifumarate (2012-02-21),

13. 7989494 - Polymorphs of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide (2011-08-02),

Title: The Innovative Contributions of Frank Stowasser

Introduction

Frank Stowasser is a notable inventor based in Murg, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work focuses on developing innovative solutions for medical treatments, particularly in the area of viral diseases.

Latest Patents

Among his latest patents is a novel solid form of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-D]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate. This invention relates to pharmaceutical compositions that may be used as a TLR7 agonist for the treatment or prophylaxis of viral diseases, specifically those related to HBV infection. Another significant patent is for a hydrophilic gel designed for the topical delivery of 5-aminolevulinic acid (5-ALA). This pharmaceutical preparation can be utilized in photodynamic therapy and the detection of abnormally proliferating cells.

Career Highlights

Frank Stowasser has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Zimmer Biotech GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Frank has collaborated with esteemed colleagues such as Nigel Graham Cooke and Paulo Antonio Fernandes Gomes Dos Santos. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Frank Stowasser's contributions to the field of pharmaceuticals through his patents and collaborations highlight his innovative spirit and dedication to improving medical treatments. His work continues to impact the industry positively, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.